Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Antimi

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Recenti Progressi in Medicina|February 1, 1982
[Current antibacterial therapy in high-risk subjects]M Antimi
La Clinica Terapeutica|June 11, 1998
[High-dose chemotherapy of breast cancer with hematopoietic protection; current status and prospectives]M Antimi
La Clinica Terapeutica|January 6, 2001
[Differentiated thyroid carcinomas]G Marinuzzi, V Bellini, M Antimi
La Clinica Terapeutica|May 9, 2008
[Medical treatment for thymoma: an update]M Lalle, V Bellini, M Antimi
La Clinica Terapeutica|February 24, 2001
[Anaplastic, insular, and medullary carcinoma of the thyroid]G Marinuzzi, V Bellini, M Antimi
Journal of Experimental & Clinical Cancer Research : CR|August 23, 2005
Epoetin alfa 40000 U once weekly and intravenous iron supply in solid tumor patients: early increase of hemoglobin level during chemotherapyM Lalle, G Pistillucci, M Antimi, et al.
La Clinica Terapeutica|November 24, 2004
[High-dose chemotherapy for metastatic breast cancer]M Lalle, L De Rosa, A Perillo, et al.
Tumori|October 31, 1993
A phase I safety study of doxifluridine and interferon-alpha-2a in patients with advanced neoplastic diseaseM Antimi, L Majoli, M Minelli, et al.
Italian Journal of Neurological Sciences|October 1, 1991
Non-Hodgkin lymphomas of the central nervous systemF Pisani, M Antimi, M Cantonetti, et al.
The Journal of Urology|June 7, 2000
Gemcitabine plus cisplatin for advanced transitional cell carcinoma of the urinary tract: a phase II multicenter trialV Lorusso, L Manzione, F De Vita, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Recenti Progressi in Medicina|February 1, 1982
[Current antibacterial therapy in high-risk subjects]M Antimi
La Clinica Terapeutica|June 11, 1998
[High-dose chemotherapy of breast cancer with hematopoietic protection; current status and prospectives]M Antimi
La Clinica Terapeutica|January 6, 2001
[Differentiated thyroid carcinomas]G Marinuzzi, V Bellini, M Antimi
La Clinica Terapeutica|May 9, 2008
[Medical treatment for thymoma: an update]M Lalle, V Bellini, M Antimi
La Clinica Terapeutica|February 24, 2001
[Anaplastic, insular, and medullary carcinoma of the thyroid]G Marinuzzi, V Bellini, M Antimi
Journal of Experimental & Clinical Cancer Research : CR|August 23, 2005
Epoetin alfa 40000 U once weekly and intravenous iron supply in solid tumor patients: early increase of hemoglobin level during chemotherapyM Lalle, G Pistillucci, M Antimi, et al.
La Clinica Terapeutica|November 24, 2004
[High-dose chemotherapy for metastatic breast cancer]M Lalle, L De Rosa, A Perillo, et al.
Tumori|October 31, 1993
A phase I safety study of doxifluridine and interferon-alpha-2a in patients with advanced neoplastic diseaseM Antimi, L Majoli, M Minelli, et al.
Italian Journal of Neurological Sciences|October 1, 1991
Non-Hodgkin lymphomas of the central nervous systemF Pisani, M Antimi, M Cantonetti, et al.
The Journal of Urology|June 7, 2000
Gemcitabine plus cisplatin for advanced transitional cell carcinoma of the urinary tract: a phase II multicenter trialV Lorusso, L Manzione, F De Vita, et al.
Pageof 3